硫酸镁在重症胰腺炎中应用对腹腔压力及hsCRP水平影响.docVIP

硫酸镁在重症胰腺炎中应用对腹腔压力及hsCRP水平影响.doc

  1. 1、本文档共12页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
硫酸镁在重症胰腺炎中应用对腹腔压力及hsCRP水平影响

硫酸镁在重症胰腺炎中应用对腹腔压力及hsCRP水平影响   [摘要] 目的:观察硫酸镁在重症胰腺炎中应用对腹腔压力及hs-CRP水平的影响。方法:将66例诊断明确的SAP患者进行随机配对后分为硫酸镁治疗组和对照组。同时记录首次排便时间,并动态测定并记录血淀粉酶、hs-CRP值、腹腔压力水平。结果:硫酸镁治疗组平均排便时间早,所有患者在排便后血淀粉酶、hs-CRP值、腹腔压力降低明显,硫酸镁治疗组血淀粉酶、hs-CRP值、腹腔压力值较对照组明显降低,差异均有统计学意义(P<0.05);并发症发生率以及中转开腹率、死亡率明显减少。结论:硫酸镁在重症胰腺炎的应用可以有效降低腹腔压力、减轻炎症应急反应,应该早期应用,可有效降低并发症的发生率。   [关键词] 硫酸镁 重症胰腺炎 hs-CRP 腹腔压力   [中图分类号] R657.51[文献标识码]A [文章编号]1673-7210(2011)02(b)-030-03   The effect of magnesium sulphate used in severe acute pancreatitis on the the level of abdominal cavity pressure and hs-CRP   LIU Yongfan, ZENG Jian'geng, LIU Suhua, ZOU Meifeng, LIU Zhengfan   (Department of General Surgery, the Central People's Hospital of Ji'an City, Ji'an 343000, China)   [Abstract] Objective: To observe the effect of magnesium sulphate used in severe acute pancreatitis on the the level of abdominal cavity pressure and hs-CRP. Methods: 66 cases of SAP patients (diagnosis explicit) were divided into the magnesium sulfate treatment group and the control group. Simultaneously recorded for the first time of the bowel movement time, the dynamic determination, the blood amylase, the hs-CRP value and the abdominal cavity stress level. Results: Magnesium sulfate treatment group average bowel movement time was early, all patients after the bowel movement the blood amylase, the hs-CRP value, abdominal cavity pressure drop were obvious, the magnesium sulfate treatment group blood amylase, the hs-CRP value, the abdominal cavity pressure value, compared with the control group to reduce obviously, the difference had the significance (P<0.05). The incidence of the complication and the tranferred abdominal operation rate, the mortality significantly decreased. Conclusion: The magnesium sulfate can effectively reduce the abdominal cavity pressure and reduce the inflammation emergency reaction effectively when magnesium sulfate used in SAP; magnesium sulfate may be used early, it can reduce the complication effectively.   [Key words] Magnesium sulp

文档评论(0)

erterye + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档